|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004238,
umls-concept:C0019080,
umls-concept:C0026565,
umls-concept:C0030705,
umls-concept:C0032105,
umls-concept:C0035648,
umls-concept:C0042971,
umls-concept:C0085862,
umls-concept:C0205164,
umls-concept:C0332257,
umls-concept:C0441889,
umls-concept:C1299583,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C1705413
|
|
pubmed:issue |
25
|
|
pubmed:dateCreated |
2011-6-17
|
|
pubmed:abstractText |
The purpose of this study was to evaluate the prognostic value of plasma von Willebrand factor (vWF) levels and fibrin d-dimer in a large cohort of anticoagulated permanent atrial fibrillation (AF) patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
21
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2496-504
|
|
pubmed:meshHeading |
pubmed-meshheading:21497043-Aged,
pubmed-meshheading:21497043-Anticoagulants,
pubmed-meshheading:21497043-Atrial Fibrillation,
pubmed-meshheading:21497043-Biological Markers,
pubmed-meshheading:21497043-Female,
pubmed-meshheading:21497043-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:21497043-Hemorrhage,
pubmed-meshheading:21497043-Humans,
pubmed-meshheading:21497043-Male,
pubmed-meshheading:21497043-Predictive Value of Tests,
pubmed-meshheading:21497043-Risk Assessment,
pubmed-meshheading:21497043-Risk Factors,
pubmed-meshheading:21497043-Treatment Outcome,
pubmed-meshheading:21497043-von Willebrand Factor
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
|
|
pubmed:affiliation |
Hematology and Medical Oncology Unit, Hospital Universitario Morales Meseguer, University of Murcia, Murcia, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
